The Ball is in their court–Is FDA preparing to drop it?
On Wednesday, the FDA Pediatric Advisory Committee handed the agency a mixed message regarding warnings about selective list of
psychotropic drugs prescribed for treating ADHD symptoms.
AHRP Recommends FDA Actions to Protect Children Rx ADHD drugs
AHRP Urges Actions to Minimize Risks for Children prescribed psychotropic drugs: Action is needed to protect children from widespread prescribing of psychoactive drugs for ill-defined behavioral symptoms.
2.5 Million US Children Prescribed Antipsychotics_ FDA ADHD–ADR Review
The Associated Press reports that a just released study that found that a staggering, two and half million children in the U.S. are being prescribed antipsychotics annually–that’s 40 out of every 1,000 children.
FDA Review ADHD Drugs Induce-Psychosis, Mania, Homicide, Suicide
Psychiatric Adverse Events Associated with Drug Treatment of ADHD: Review of Postmarketing Safety Data
Six Healthy Volunteers in Phase I Drug Trial-Critically Ill_UK
The Phase I trial–the first in humans–was set up by US drug research company Parexel International Corp on behalf of German pharmaceutical company TeGenero.
AHRP Letter to FDA Commissioner-Themirosal
Our questions Re: Thimerosal are threefold.
Mercury Crimes at CDC
"It’s time for the CDC to come clean with the American public. Its tactics of deception and obfuscation are jeopardizing the credibility of the entire vaccine program, and therefore posing an enormous danger to public health." Robert Kennedy, Jr. See letter to FDA Commissioner.
Fix the Diagnosis, Not the Children
From both sides of the Atlantic, even psychiatrists are acknowledging–the ADHD diagnosis makes no sense.
FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug
“When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease. Last year, she died at the age of 46 from an infection linked to the drug.”
UK-MHRA Drug-Related Suicide Reports_Yellow Card
The UK adverse event drug reporting system utilizes the Yellow Card system for filing reports.
Comparison of Suicide Rates in Treated Schizophrenia Patients Found 20-Fold Increase
An analysis published in the current issue of the British J of Psychiatry (BJP) of the suicide rate among schizophrenia patients treated at the same hospital in North Wales (UK) before psychotropic drugs and patients treated (in and out of hospital) with neuroleptics and /or atypical antipsychotics, found a 20-fold increase in the suicide rate since use of psychotropic drugs.
ADHD Drugs Addictive_NIDA study
"More than 7 million americans are estimated to have misused stimulant drugs."